企業プロフィール
Indivior 株価・ニュース・カタリスト
- ティッカー:
- INDV
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom and listed in the U
株価パフォーマンス
39.08 USD (+0.18%)
終値
最終更新: 2026年8月17日
3.98B USD
時価総額
株価変動の要因
As of Aug 17, 2026, INDV was little changed and closed at $39.08. No new same-company headline was identified in the current news window.
企業概要
Addiction Medicine
Indivior develops and commercializes medicines for substance-use disorders. Its strategy emphasizes long-acting formulations that support sustained treatment while reducing the burden and diversion risks associated with daily medication.
SUBLOCADE Franchise
SUBLOCADE is a monthly extended-release buprenorphine injection for opioid-use disorder and is the company’s primary commercial product. The formulation is administered by healthcare professionals and provides continuous buprenorphine exposure over the dosing interval.
Focused Portfolio Strategy
Indivior is concentrating resources on its marketed addiction franchise after deciding not to internally advance INDV-2000 and not to pursue Phase 3 development of INDV-6001. It retains potential U.S. commercial rights to a future viable product developed by the INDV-6001 licensor.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。